Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Cryo Cell International (CCEL) over the last 14 years, with Q3 2025 value amounting to $20.8 million.

  • Cryo Cell International's Long-Term Deferred Tax rose 150.92% to $20.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $20.8 million, marking a year-over-year increase of 150.92%. This contributed to the annual value of $20.8 million for FY2024, which is 150.92% up from last year.
  • As of Q3 2025, Cryo Cell International's Long-Term Deferred Tax stood at $20.8 million, which was up 150.92% from $20.8 million recorded in Q2 2025.
  • Cryo Cell International's Long-Term Deferred Tax's 5-year high stood at $20.8 million during Q4 2024, with a 5-year trough of $10.4 million in Q1 2021.
  • Its 5-year average for Long-Term Deferred Tax is $15.8 million, with a median of $13.7 million in 2022.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first surged by 4912.06% in 2023, then surged by 150.92% in 2024.
  • Cryo Cell International's Long-Term Deferred Tax (Quarter) stood at $12.0 million in 2021, then rose by 14.42% to $13.7 million in 2022, then skyrocketed by 49.12% to $20.5 million in 2023, then grew by 1.51% to $20.8 million in 2024, then changed by 0.0% to $20.8 million in 2025.
  • Its last three reported values are $20.8 million in Q3 2025, $20.8 million for Q2 2025, and $20.8 million during Q1 2025.